CRDL
Cardiol Therapeutics
CRDL
CRDL
35 hedge funds and large institutions have $5.78M invested in Cardiol Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.58% less ownership
Funds ownership: 10.45% → 9.86% (-0.58%)
3% less capital invested
Capital invested by funds: $5.97M → $5.78M (-$190K)
Holders
35
Holding in Top 10
–
Calls
$5K
Puts
$1K
Top Buyers
| 1 | +$133K | |
| 2 | +$62K | |
| 3 | +$34.6K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$30K |
| 5 |
MA
MONECO Advisors
Fairfield,
Connecticut
|
+$12.5K |
Top Sellers
| 1 | -$480K | |
| 2 | -$32.6K | |
| 3 | -$22.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15.8K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$12.8K |